Highlights ENDRA Life Sciences Inc.

Equities

NDRA

US29273B3024

Real-time Estimate Cboe BZX Other stock markets 10:35:46 2024-05-13 am EDT			5-day change	1st Jan Change
0.298 ^USD	-0.33%		-8.43%	-86.06%

May. 10	ENDRA Life Sciences Inc. Provides Earnings Guidance for the Quarter Ended March 31, 2024	CI
Mar. 28	Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ENDRA Life Sciences Inc. Provides Earnings Guidance for the Quarter Ended March 31, 2024	May. 10	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
ENDRA Life Sciences Inc. Welcomes the Adoption of the ICD-10 K76.0 Code for the Diagnosis of Non-Alcoholic Fatty Liver Disease	Feb. 21	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
ENDRA Life Sciences Submits De Novo Request for its TAEUS System Liver Fat Application to the U.S. FDA	23-08-14	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Endra Life Sciences Says de Novo Application for TAEUS Monitor Due in 'Coming Weeks'	22-09-29	MT
ENDRA Life Sciences Inc. Plans to Submit De Novo Request to U.S. FDA for Its TAEUS System	22-09-29	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
ENDRA Life Sciences Secures Three Patents for Cloud-Enabled Connectivity of Medical Devices	22-08-02	MT
ENDRA Life Sciences Granted Two Chinese Patents for TAEUS System	22-07-11	MT
ENDRA Life Sciences Gets New US Patent for Thermo Acoustic UltraSound Device	22-06-28	MT
ENDRA Life Sciences Receives US Patent Covering TAEUS System	22-05-25	MT
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Endra Life Sciences Says It Secured US Patent That Protects Method for Determining Material Type	22-03-08	MT
Endra Life Sciences Awarded Two European Patents for Methods of Calculating Body Fat Concentration	22-02-11	MT
ENDRA Life Sciences Inc. Provides Update on U.S. Regulatory Strategy for its TAEUS® System	22-02-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ENDRA Life Sciences Inc.

Equities

NDRA

US29273B3024

Highlights

Filters